✦ LIBER ✦
P-946 Why do non smokers with non-small cell lung cancer (NSCLC) who receive erlotinib have better clinical outcomes than smokers?
✍ Scribed by Clark, G.; Cagnoni, P.; Ptaszynski, M.; Hamilton, M.; Santabárbara, P.; Christy-Bittel, J.; Geiger, B.; McCarthy, S.; Onetto, N.
- Book ID
- 122921230
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 149 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.